WASHINGTON (NewsNation Now) — The FDA announced the Pfizer-BioNTech coronavirus vaccine has been authorized for emergency use in adolescents 12-15-years-old.
Previously, only those 16+ were eligible for the vaccine. The company had announced recently they would seek authorization to expand the age range,
“Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations,” said Acting FDA Commissioner Janet Woodcock, M.D.
Studies conducted by Pfizer showed the vaccine not only was safe for teenagers, but also nearly eliminated all risk of catching COVID-19.
The company did note that some children have similar reactions to adults from the second shot including fever, chills, and aches.
Read the full EUA:
This is a developing story, check back soon for updates